Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

We carried out a phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin to determine the maximum tolerated dose and recommended dose and to evaluate the efficacy and safety of this treatment in patients with esophageal carcinoma. Thoracic esophageal cancer patients with clinical sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahara, Makoto, Fuse, Nozomu, Mizusawa, Junki, Sato, Akihiro, Nihei, Keiji, Kanato, Keisuke, Kato, Ken, Yamazaki, Kentaro, Muro, Kei, Takaishi, Hiromasa, Boku, Narikazu, Ohtsu, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638006/
https://www.ncbi.nlm.nih.gov/pubmed/26250827
http://dx.doi.org/10.1111/cas.12764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638006/
https://www.ncbi.nlm.nih.gov/pubmed/26250827
http://dx.doi.org/10.1111/cas.12764

Ejemplares similares